Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1907 of 6351
-
Could a silver gel halt cavities without the drill?
Disease control CompletedA single group observational study to determine the clinical response of dental caries lesions in primary teeth where 38% silver diamine fluoride gel is applied and cover with 2.5% sodium fluoride varnish. Additionally, to assess parent satisfaction with treatment with 38% silver…
Sponsor: Advantage Silver Dental Arrest, LLC • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Endoscopic obesity treatments under 10-Year microscope
Disease control By invitation onlyThis is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.
Sponsor: Christopher C. Thompson, MD, MSc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Baby breathing treatment: gene test may end guesswork for albuterol in bronchiolitis
Knowledge-focused Recruiting nowBronchiolitis is the leading cause of pediatric morbidity and healthcare costs. Despite the commonplace use of bronchodilator treatments, like albuterol, in conditions like asthma, their efficacy in bronchiolitis remains controversial due to the heterogeneity in patient response.…
Phase 3 • Sponsor: Nemours Children's Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Iron infusions may boost gut healing in celiac disease
Disease control Stopped earlyThe study aims is to evaluate the efficacy of intravenous iron supplementation on celiac disease remission (total intestinal mucosal recovery). This randomized multicenter trial compare the administration of intravenous iron by infusion (Ferinject©: 15 mg/kg in NaCl solution in 3…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Magic mushroom therapy takes on meth addiction in veterans
Disease control OngoingThis is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
Phase 1/2 • Sponsor: Portland VA Research Foundation, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail targets Hard-to-Treat bladder cancer
Disease control OngoingThis phase Ib trial evaluates the best dose, potential benefits, and/or side effects of erdafitinib in combination with enfortumab vedotin in treating patients with bladder cancer that has spread from where it first started (primary site) to other places in the body (metastatic) …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New Steroid-Like drug tested for muscle disease
Disease control CompletedThis Phase II pilot study is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, PK, PD, and exploratory clinical efficacy of vamorolone 500mg (250mg for body weight \<50 kg) daily administered orally compared to placebo over a treatment per…
Phase 2 • Sponsor: ReveraGen BioPharma, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:34 UTC
-
Automated insulin pump takes on type 1 diabetes in Head-to-Head trial
Disease control CompletedSubject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the …
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
New drug cocktail targets rare eye cancer
Disease control CompletedBecause we suspect that the benefit of anti-PD-1 in metastatic UM patients could vary according to previous exposure to Tebentafusp (better efficacy of anti-PD-1 after Tebentafusp), the combination of pembrolizumab and lenvatinib will be assessed in two independent cohorts: cohor…
Phase 2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a nasal spray stop the next flu pandemic?
Vaccine CompletedThe purpose of this clinical trial is to evaluate the safety and immunogenicity of BW-1014. BW-1014 is a nanoemulsion (NE) adjuvanted recombinant Hemagglutinin 5 (rH5) that would protect against pandemic flu. The study will be conducted in 40 healthy adults volunteers, age 18 -…
Phase 1 • Sponsor: BlueWillow Biologics • Aim: Vaccine
Last updated Aug 01, 2026 00:00 UTC
-
Immunotherapy combo may delay progression in advanced bladder cancer
Disease control CompletedImmunotherapy has improved clinical outcomes in metastatic urothelial carcinoma (mUC). Second-line treatment after progression to platinum-containing chemotherapy with immune checkpoint inhibitors (ICIs) have antitumor activity in advanced / metastatic UC and provide favorable sa…
Phase 2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise for Hard-to-Treat cancers with BRAF mutation
Disease control OngoingThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines in people with solid tumors. This study is seeking participants who have an advance…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug aims to tame muscle inflammation in myositis
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo shrinks rectal tumors before surgery
Disease control CompletedTASOX can be safely and efficaciously delivered after short course radiation, resulting in significant pathologic downstaging, allowing for an R0 pelvic resection, and providing local control in appropriately selected stage II/III rectal cancer patients treated with contemporary …
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Spinal implant offers new hope for diabetic leg pain
Symptom relief OngoingThe purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study,…
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New pill aims to ease schizophrenia psychosis
Symptom relief CompletedThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 6-week trial to evaluate the efficacy, safety, and tolerability of 2 fixed doses of CVL-231 (Emraclidine) (15 mg QD and 30 mg QD) in male and female adult participants who have schizophr…
Phase 2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can intensive arm training help stroke survivors regain movement?
Symptom relief CompletedThe evidence supporting routine provision of high-dose, high-intensity upper limb neurorehabilitation treatment for stroke survivors beyond the first few months after stroke is limited. The Queen Square Upper Limb (QSUL) programme provides 90 hours of upper limb neurorehabilitati…
Phase 2 • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Experimental gene therapy aims to restore sight in rare eye disease
Disease control OngoingThe purpose of the study is to evaluate the safety, tolerability and efficacy of LX101 in subjects with biallelic RPE65 mutation-associated inherited retinal dystrophy.
Phase 1 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Sound waves vs. high blood pressure: new device shows promise
Disease control OngoingTo compare the antihypertensive effect of renal denervation with the Paradise™ system with that of a sham procedure in hypertensive patients receiving two antihypertensive drugs at the time of consent, and treated with a duo combination antihypertensive pill.
Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New triple therapy shows promise for resistant cancers
Disease control CompletedThis is a multicenter, open-label, dose-escalation and efficacy/safety Phase I/II study to assess RP2D, safety, tolerability and anti-tumor activity of Sintilimab + afuresertib + nab-paclitaxel or docetaxel administered as a combination therapy. This study is designed to identif…
Phase 1/2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC